Commonwealth Equity Services
CSCI

Commonwealth Equity Services’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Commonwealth Equity Services’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$11K – 3590
2021
Q1 		$11K Buy
+100
New +$11.1K ﹤0.01% 3392

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Commonwealth Equity Services's CSCI Position: Q2 2021 in Review

Commonwealth Equity Services sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2021, closing a stake of 100 shares — an estimated $11K sold.

Commonwealth Equity Services first reported a position in CSCI in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 34 funds tracked by Wall St. Rank hold CSCI as of Q2 2021.

  • Commonwealth Equity Services reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 100 COSCIENS Biopharma Inc. Common Stock shares in Q2 2021, an estimated $11K.
  • Commonwealth Equity Services first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Commonwealth Equity Services's COSCIENS Biopharma Inc. Common Stock position peaked at $11K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2021.

Based on Commonwealth Equity Services's 13F filing for Q2 2021, filed 11 Aug 2021.